A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small amounts of common food allergens. OIT, the most common approach to treating food allergy in the United States, involves eating gradually increasing doses of a food… Continue reading Omalizumab outperforms oral immunotherapy in treating multi-food allergy
Category: Immunology
Innovative AI-enabled, low-cost device makes flow cytometry accessible for clinical use
A team of researchers at the George R. Brown School of Engineering and Computing at Rice University has developed an innovative artificial intelligence (AI)-enabled, low-cost device that will make flow cytometry ⎯ a technique used to analyze cells or particles in a fluid using a laser beam ⎯ affordable and accessible. The prototype identifies and counts cells… Continue reading Innovative AI-enabled, low-cost device makes flow cytometry accessible for clinical use
Researchers uncover how brain tumors reprogram neutrophils to hinder cancer treatment
The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive brain cancers reprogram immune system cells from fighting cancer to enabling further tumor growth. The team’s findings were published in the paper “Functional reprogramming of neutrophils within the brain tumor microenvironment by hypoxia-driven histone lactylation,” from… Continue reading Researchers uncover how brain tumors reprogram neutrophils to hinder cancer treatment